BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35359747)

  • 21. Laser interstitial thermal therapy (LITT) vs. bevacizumab for radiation necrosis in previously irradiated brain metastases.
    Sujijantarat N; Hong CS; Owusu KA; Elsamadicy AA; Antonios JP; Koo AB; Baehring JM; Chiang VL
    J Neurooncol; 2020 Jul; 148(3):641-649. PubMed ID: 32602021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain Metastases.
    Tanenbaum DG; Buchwald ZS; Jhaveri J; Schreibmann E; Switchenko JM; Prabhu RS; Chowdhary M; Abugideiri M; Pfister NT; Eaton B; Kahn SE; Olson JJ; Shu HG; Crocker IR; Curran WJ; Patel KR
    Pract Radiat Oncol; 2020; 10(1):36-43. PubMed ID: 31586666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bevacizumab treatment leads to observable morphological and metabolic changes in brain radiation necrosis.
    Yonezawa S; Miwa K; Shinoda J; Nomura Y; Asano Y; Nakayama N; Ohe N; Yano H; Iwama T
    J Neurooncol; 2014 Aug; 119(1):101-9. PubMed ID: 24789256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of a questionnaire regarding practice patterns for the diagnosis and treatment of intracranial radiation necrosis after SRS.
    Stockham AL; Ahluwalia M; Reddy CA; Suh JH; Kumar A; Vogelbaum MA; Barnett GH; Murphy ES; Chao ST
    J Neurooncol; 2013 Dec; 115(3):469-75. PubMed ID: 24045970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation Necrosis from Stereotactic Radiosurgery-How Do We Mitigate?
    Vellayappan BA; McGranahan T; Graber J; Taylor L; Venur V; Ellenbogen R; Sloan AE; Redmond KJ; Foote M; Chao ST; Suh JH; Chang EL; Sahgal A; Lo SS
    Curr Treat Options Oncol; 2021 Jun; 22(7):57. PubMed ID: 34097171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis.
    Patel KR; Chowdhary M; Switchenko JM; Kudchadkar R; Lawson DH; Cassidy RJ; Prabhu RS; Khan MK
    Melanoma Res; 2016 Aug; 26(4):387-94. PubMed ID: 27223498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma.
    Fang P; Jiang W; Allen P; Glitza I; Guha N; Hwu P; Ghia A; Phan J; Mahajan A; Tawbi H; Li J
    J Neurooncol; 2017 Jul; 133(3):595-602. PubMed ID: 28500560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: An international multicenter study.
    Lehrer EJ; Gurewitz J; Bernstein K; Patel D; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Malouff TD; Ruiz-Garcia H; Patel S; Bonney PA; Hwang L; Yu C; Zada G; Mathieu D; Trudel C; Prasad RN; Palmer JD; Jones BM; Sharma S; Fakhoury KR; Rusthoven CG; Deibert CP; Picozzi P; Franzini A; Attuati L; Lee CC; Yang HC; Ahluwalia MS; Sheehan JP; Trifiletti DM
    Cancer; 2022 Apr; 128(7):1429-1438. PubMed ID: 35077586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Liquid Biopsy to Assess Brain Tumor Recurrence: Presence of Circulating Mo-MDSC and CD14+ VNN2+ Myeloid Cells as Biomarkers That Distinguish Brain Metastasis From Radiation Necrosis Following Stereotactic Radiosurgery.
    Soler DC; Kerstetter-Fogle A; Elder T; Raghavan A; Barnholtz-Sloan JS; Cooper KD; McCormick TS; Sloan AE
    Neurosurgery; 2020 Dec; 88(1):E67-E72. PubMed ID: 32823285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation.
    Zhuang H; Yuan X; Chang JY; Song Y; Wang J; Yuan Z; Wang X; Wang P
    Oncotarget; 2016 Jul; 7(30):48842-48849. PubMed ID: 26934327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-stereotactic radiosurgery brain metastases: a review.
    Fabiano AJ; Qiu J
    J Neurosurg Sci; 2015 Jun; 59(2):157-67. PubMed ID: 25600555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
    Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
    Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time to Steroid Independence After Laser Interstitial Thermal Therapy vs Medical Management for Treatment of Biopsy-Proven Radiation Necrosis Secondary to Stereotactic Radiosurgery for Brain Metastasis.
    Sankey EW; Grabowski MM; Srinivasan ES; Griffin AS; Howell EP; Otvos B; Tsvankin V; Barnett GH; Mohammadi AM; Fecci PE
    Neurosurgery; 2022 Jun; 90(6):684-690. PubMed ID: 35311745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients.
    Wang Y; Pan L; Sheng X; Mao Y; Yao Y; Wang E; Zhang N; Dai J
    Eur J Med Res; 2012 Aug; 17(1):25. PubMed ID: 22913802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases.
    Furuse M; Kawabata S; Kuroiwa T; Miyatake S
    J Neurooncol; 2011 May; 102(3):471-5. PubMed ID: 20694573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery.
    Blonigen BJ; Steinmetz RD; Levin L; Lamba MA; Warnick RE; Breneman JC
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):996-1001. PubMed ID: 19783374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic radiosurgery with whole brain radiotherapy combined with bevacizumab in the treatment of brain metastases from NSCLC.
    Li L; Feng M; Xu P; Wu YL; Yin J; Huang Y; Tan MY; Jinyi L
    Int J Neurosci; 2023 Mar; 133(3):334-341. PubMed ID: 33843421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of bevacizumab and LITT for treating radiation necrosis in previously radiated CNS neoplasms: a systematic review and meta-analysis.
    Gecici NN; Gurses ME; Kaye B; Jimenez NLF; Berke C; Gökalp E; Lu VM; Ivan ME; Komotar RJ; Shah AH
    J Neurooncol; 2024 May; 168(1):1-11. PubMed ID: 38619777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.